Table 1 Characteristics of the Pediatric MDS Cohort

From: The genomic landscape of pediatric myelodysplastic syndromes

 

Total

DNA Seq. Technique

RNA Seq.

Tumor/Normal Pairs (n = 54)

Primary MDS

32

WES

25

MDS/MPN

14

WES

12

AML-MRC

8

WES

6

Tumor Only (n = 23)

Primary MDS

14

TSCA

Not Done

MDS/MPN

9

TSCA

Not Done

AML-MRC

0

TSCA

Not Done

Total

77

 

43

  1. TSCA, TruSeq Custom Amplicon; WES, Whole-exome sequencing